Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner

  • Sunday, May 5th
    2:00 PM – 3:30 PM ET
    Pediatric Therapeutics and Pharmacology
    Location: Metro Toronto Convention Centre: 501
    Moderator: Dinah Kate H. Thibeault, MD (she/her/hers) – Comer Children's Hospital at University of Chicago Medical Center
    Moderator: Diane E. Hindman, MD PharmD FAAP FACMT (she/her/hers) – Phoenix Children's Hospital
    Therapeutics and Pharmacology
     CE Live CME: 1.5
  • Sunday, May 5th
    2:00 PM – 2:15 PM ET
    Pharmacokinetic Model-Guided Enoxaparin Dosing in the NICU: Retrospective Analysis to Plan for Prospective Feasibility Trial
    Location: Metro Toronto Convention Centre: 501
    Presenting Author: Tamorah Lewis, MD, PhD (she/her/hers) – University of Toronto Temerty Faculty of Medicine
    Therapeutics and Pharmacology
     CE Enduring CME: 0.25
  • Sunday, May 5th
    2:15 PM – 2:30 PM ET
    Caregiver Liquid Ibuprofen Dosing Errors in the Outpatient Setting
    Location: Metro Toronto Convention Centre: 501
    Presenting Author: Karina Phang, MD, MPH (she/her/hers) – Geisinger Health System
    Therapeutics and Pharmacology
     CE Enduring CME: 0.25
  • Sunday, May 5th
    2:30 PM – 2:45 PM ET
    Therapeutic Drug Monitoring (TDM) Of Rituximab To Predict Early B-Cell Repopulation In Children
    Location: Metro Toronto Convention Centre: 501
    Presenting Author: Ruud H.J. Verstegen, MD PhD (he/him/his) – The Hospital for Sick Children
    Therapeutics and Pharmacology
     CE Enduring CME: 0.25
  • Sunday, May 5th
    2:45 PM – 3:00 PM ET
    Enhancing Precision Medicine in Pediatric Organ Transplant: Leveraging Pharmacogenetics for Improved Treatment Outcomes
    Location: Metro Toronto Convention Centre: 501
    Presenting Author: Sierra Scodellaro, BSc., MHSc. (she/her/hers) – The Hospital for Sick Children
    Therapeutics and Pharmacology
     CE Enduring CME: 0.25
  • Sunday, May 5th
    3:15 PM – 3:30 PM ET
    Safety and tolerability of Remdesivir for severe infection and prevention of progression of disease in pediatric patients with SARS-CoV-2 infection
    Location: Metro Toronto Convention Centre: 501
    Presenting Author: Delma J. Nieves, MD (she/her/hers) – University of California, Irvine, School of Medicine
    Therapeutics and Pharmacology
     CE Enduring CME: 0.25